What is CHE stock price today?

Visit our real-time dashboard for the current CHE stock price and live market data.

Is CHE stock going up or down today?

CHE stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CHE stock now?

The decision to buy CHE depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CHE a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CHE based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CHE stock overvalued or undervalued?

CHE currently trades at a P/E ratio of 23.81 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if CHE is fairly priced.

What is CHE's P/E ratio?

CHE has a price-to-earnings (P/E) ratio of 23.81, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is CHE's market cap?

CHE (Chemed Corp) has a market capitalization of $5.79 billion, making it a small-cap stock.

What is CHE's price to book ratio?

CHE trades at a price-to-book (P/B) ratio of 6.83, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does CHE pay dividends?

Yes, CHE pays dividends with a current yield of 0.53%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is CHE's dividend yield?

CHE's dividend yield is 0.53%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is CHE stock a good long-term investment?

CHE's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CHE's revenue growth rate?

Revenue growth data for CHE is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CHE are available on our dashboard with complete income statement analysis.

What are the risks of investing in CHE?

Key risks for CHE include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CHE compare to its competitors?

Compare CHE to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHE's performance and positioning.

What is CHE's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CHE with bull, base, and bear case scenarios.

What do analysts say about CHE?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHE. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CHE's next earnings report?

CHE reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CHE - Chemed Corp

NYSE * Healthcare * Medical Care Facilities

$0.00

+$0.00 (+0.00%)

About Chemed Corp

Chemed Corp (CHE) common stock

Price Chart

Loading chart...

CHE Key Statistics

Market Cap

$5.79B

P/E Ratio

23.81

P/B Ratio

6.83

Dividend Yield

0.53%

How CHE Compares to Peers

CHE is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CHE(This stock)	$5.79B	23.8	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 16, 2026 at 6:14 PM EDT

Ready to invest in CHE?

Commission-free trading available. Affiliate links.

CHE Lician Score

10% confidence

5.0/10

Neutral

CHE has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

4.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CHEacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CHE Financial Snowflake

5-axis analysis across key investment dimensions

4.8/10

Neutral

5.0

Value

Valuation vs. sector peers

4.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CHE

Dashboard

Enter a ticker to analyze